DOI: 10.1055/s-00000134

Diabetologie und Stoffwechsel

LinksClose Window

References

Ryan PB, Buse JB, Schuemie MJ. et al.
Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSERVE-4D).

Diabetes Obes Metab 2018; 1-13

Download Bibliographical Data

We do not assume any responsibility for the contents of the web pages of other providers.